Ghiam Yamin, Ph.D. - Publications

Affiliations: 
University of California, Los Angeles, Los Angeles, CA 
Area:
Alzheimer's disease

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Yamin G, Teplow DB. Pittsburgh Compound-B (PiB) binds amyloid β-protein protofibrils. Journal of Neurochemistry. PMID 27943341 DOI: 10.1111/Jnc.13887  0.649
2016 Yamin G, Coppola G, Teplow DB. Design, characterization, and use of a novel amyloid β-protein control for aggregation and neurotoxicity assays. Biochemistry. PMID 27505174 DOI: 10.1021/Acs.Biochem.6B00579  0.654
2015 Yamin G, Huynh TP, Teplow DB. Design and Characterization of Chemically Stabilized Aβ42 Oligomers. Biochemistry. 54: 5315-21. PMID 26241378 DOI: 10.1021/Acs.Biochem.5B00318  0.647
2015 Hayden EY, Yamin G, Beroukhim S, Chen B, Kibalchenko M, Jiang L, Ho L, Wang J, Pasinetti GM, Teplow DB. Inhibiting amyloid β-protein assembly: Size-activity relationships among grape seed-derived polyphenols. Journal of Neurochemistry. PMID 26228682 DOI: 10.1111/Jnc.13270  0.627
2009 Yamin G, Ruchala P, Teplow DB. A peptide hairpin inhibitor of amyloid beta-protein oligomerization and fibrillogenesis. Biochemistry. 48: 11329-31. PMID 19877710 DOI: 10.1021/Bi901325G  0.654
2009 Yamin G. NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus. Journal of Neuroscience Research. 87: 1729-36. PMID 19170166 DOI: 10.1002/Jnr.21998  0.433
2008 Yamin G, Ono K, Inayathullah M, Teplow DB. Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease. Current Pharmaceutical Design. 14: 3231-46. PMID 19075703 DOI: 10.2174/138161208786404137  0.656
2007 Grant MA, Lazo ND, Lomakin A, Condron MM, Arai H, Yamin G, Rigby AC, Teplow DB. Familial Alzheimer's disease mutations alter the stability of the amyloid beta-protein monomer folding nucleus. Proceedings of the National Academy of Sciences of the United States of America. 104: 16522-7. PMID 17940047 DOI: 10.1073/Pnas.0705197104  0.662
2005 Yamin G, Munishkina LA, Karymov MA, Lyubchenko YL, Uversky VN, Fink AL. Forcing nonamyloidogenic beta-synuclein to fibrillate. Biochemistry. 44: 9096-107. PMID 15966733 DOI: 10.1021/Bi048778A  0.319
Show low-probability matches.